\-\ Texto\\:\\ \ \(0\)\
\-\ healthy\\ appearing\\ male\\ with\\ normal\\ vital\\ signs\\.\\ \\ mild\\ crepitus\\ of\\ bilateral\\ knees\\ without\\ focal\\ tenderness\\,\\ effusion\\ or\\ ligamentous\\ laxity\\.\ \(0\)\
\-\ labs\\,\\ to\\ include\\ cbc\\,\\ chem\\ 17\\,\\ ua\\ and\\ lipid\\ panel\\ are\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ chondrocalcinosis\ \(30\)\
\-\ aging\ \(1605\)\
\-\ cppd\ \(0\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ h\\/o\\ trauma\ \(3\)\
\-\ gout\ \(75\)\
\-\ hemachromatosis\ \(0\)\
\-\ chronic\\ bilateral\\ knee\\ pain\\.\\ \\ no\\ other\\ joint\\ complaints\\ or\\ significant\\ medical\\ problems\\.\\ \\ no\\ recalled\\ history\\ of\\ trauma\\.\ \(0\)\
\-\ as\\ the\\ patient\\ complained\\ of\\ isolated\\ knee\\ pain\\ without\\ lab\\ values\\ to\\ support\\ crystalline\\ arthropathy\\ or\\ metabolic\\ disorder\\,\\ this\\ chondrocalcinosis\\ is\\ less\\ likely\\ to\\ be\\ secondary\\ to\\ a\\ systemic\\ metabolic\\ disorder\\.\\ \\ no\\ other\\ joints\\ are\\ affected\\,\\ and\\ there\\ are\\ no\\ significant\\ degenerative\\ changes\\ of\\ the\\ knees\\ noted\\ on\\ plain\\ films\\.\\ \\ in\\ light\\ of\\ normal\\ labs\\,\\ this\\ chondrocalcinosis\\ is\\ likely\\ a\\ senescent\\ change\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chondrocalcinosis\\:\\ 0\\.3783088211858823\ \(0\)\
\-\ knees\\:\\ 0\\.22294616823408686\ \(0\)\
\-\ metabolic\\:\\ 0\\.19394781442205747\ \(0\)\
\-\ disorder\\:\\ 0\\.18096958042737046\ \(0\)\
\-\ hemachromatosis\\:\\ 0\\.1580710824335045\ \(0\)\
\-\ senescent\\:\\ 0\\.1538866021716984\ \(0\)\
\-\ knee\\:\\ 0\\.15335045644418446\ \(0\)\
\-\ labs\\:\\ 0\\.14822041749586784\ \(0\)\
\-\ crystalline\\:\\ 0\\.1475769354818254\ \(0\)\
\-\ no\\:\\ 0\\.1391424782699083\ \(0\)\
\-\ aging\\:\\ 0\\.13910112330713414\ \(0\)\
\-\ recalled\\:\\ 0\\.13596845594654888\ \(0\)\
\-\ normal\\:\\ 0\\.131026127236637\ \(0\)\
\-\ likely\\:\\ 0\\.12784596426808406\ \(0\)\
\-\ crepitus\\:\\ 0\\.12526936253931462\ \(0\)\
\-\ trauma\\:\\ 0\\.12424887396480745\ \(0\)\
\-\ lipid\\:\\ 0\\.12370575608621216\ \(0\)\
\-\ significant\\:\\ 0\\.12352492756051388\ \(0\)\
\-\ laxity\\:\\ 0\\.12297027303470882\ \(0\)\
\-\ chem\\:\\ 0\\.12226255077884163\ \(0\)\
\-\ are\\:\\ 0\\.12177142484522233\ \(0\)\
\-\ cppd\\:\\ 0\\.11849949081435315\ \(0\)\
\-\ bilateral\\:\\ 0\\.1149798877085275\ \(0\)\
\-\ without\\:\\ 0\\.11284593175341685\ \(0\)\
\-\ panel\\:\\ 0\\.11227117962747458\ \(0\)\
\-\ or\\:\\ 0\\.11163949335767893\ \(0\)\
\-\ other\\:\\ 0\\.11110309241522172\ \(0\)\
\-\ ligamentous\\:\\ 0\\.10926436786700158\ \(0\)\
\-\ arthropathy\\:\\ 0\\.10825047694842603\ \(0\)\
\-\ gout\\:\\ 0\\.10792433978843366\ \(0\)\
\-\ to\\:\\ 0\\.10696975224302965\ \(0\)\
\-\ of\\:\\ 0\\.10466835761700916\ \(0\)\
\-\ support\\:\\ 0\\.1038696345361025\ \(0\)\
\-\ complained\\:\\ 0\\.10310412359343117\ \(0\)\
\-\ ua\\:\\ 0\\.10212975305624275\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.10189387052433821\ \(0\)\
\-\ isolated\\:\\ 0\\.10166091828606062\ \(0\)\
\-\ values\\:\\ 0\\.0986712633557208\ \(0\)\
\-\ lab\\:\\ 0\\.09661670757246213\ \(0\)\
\-\ vital\\:\\ 0\\.09525229403658599\ \(0\)\
\-\ systemic\\:\\ 0\\.09492615687659361\ \(0\)\
\-\ problems\\:\\ 0\\.09278942694922263\ \(0\)\
\-\ light\\:\\ 0\\.09264572958685781\ \(0\)\
\-\ joints\\:\\ 0\\.09194330986574316\ \(0\)\
\-\ degenerative\\:\\ 0\\.09087145162426245\ \(0\)\
\-\ healthy\\:\\ 0\\.09074167661478748\ \(0\)\
\-\ cbc\\:\\ 0\\.08925063349058764\ \(0\)\
\-\ complaints\\:\\ 0\\.0880927092966684\ \(0\)\
\-\ affected\\:\\ 0\\.0879807542535243\ \(0\)\
\-\ 17\\:\\ 0\\.08732270729565265\ \(0\)\
\-\ appearing\\:\\ 0\\.08547671829336334\ \(0\)\
\-\ films\\:\\ 0\\.08471120735069203\ \(0\)\
\-\ limits\\:\\ 0\\.08452461462682302\ \(0\)\
\-\ change\\:\\ 0\\.08105928579327965\ \(0\)\
\-\ effusion\\:\\ 0\\.07943404439881595\ \(0\)\
\-\ pain\\:\\ 0\\.07655602947609251\ \(0\)\
\-\ signs\\:\\ 0\\.07476064669209699\ \(0\)\
\-\ this\\:\\ 0\\.07351404409109719\ \(0\)\
\-\ less\\:\\ 0\\.0727738550916424\ \(0\)\
\-\ plain\\:\\ 0\\.07057616643029085\ \(0\)\
\-\ joint\\:\\ 0\\.0704881267661038\ \(0\)\
\-\ medical\\:\\ 0\\.06798409080594285\ \(0\)\
\-\ tenderness\\:\\ 0\\.06708380205062421\ \(0\)\
\-\ changes\\:\\ 0\\.06464856553425172\ \(0\)\
\-\ focal\\:\\ 0\\.0639849736418273\ \(0\)\
\-\ include\\:\\ 0\\.06364652876319624\ \(0\)\
\-\ chronic\\:\\ 0\\.06349468652444663\ \(0\)\
\-\ secondary\\:\\ 0\\.0634041678578067\ \(0\)\
\-\ mild\\:\\ 0\\.06063858771338941\ \(0\)\
\-\ is\\:\\ 0\\.05858924715759684\ \(0\)\
\-\ noted\\:\\ 0\\.056715651635839616\ \(0\)\
\-\ within\\:\\ 0\\.049267356421988304\ \(0\)\
\-\ male\\:\\ 0\\.04762742285985576\ \(0\)\
\-\ and\\:\\ 0\\.044208326704072355\ \(0\)\
\-\ be\\:\\ 0\\.04339369302014963\ \(0\)\
\-\ as\\:\\ 0\\.04297388352761865\ \(0\)\
\-\ the\\:\\ 0\\.042689018588429994\ \(0\)\
\-\ there\\:\\ 0\\.04256326686823626\ \(0\)\
\-\ history\\:\\ 0\\.04086895902915948\ \(0\)\
\-\ patient\\:\\ 0\\.034792163770658996\ \(0\)\
\-\ on\\:\\ 0\\.03230695512607358\ \(0\)\
\-\ in\\:\\ 0\\.026610811836007855\ \(0\)\
\-\ with\\:\\ 0\\.020946179387148847\ \(0\)\
